FDA approved drug

CHICAGO, June 11, 2026 Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holdings, Inc., announced that the U.S....

CRANFORD, N.J., March 31, 2026 Citius Oncology, Inc. has reported strong early momentum following the U.S. launch of its...

San Diego, USA – March 26, 2026 Crinetics Pharmaceuticals announced the submission of a Marketing Authorization Application (MAA) to...

Torrance, California | December 30, 2025 — Emmaus Life Sciences, Inc. has announced a strategic licensing and exclusive distribution...